X-Zyme Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
1
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
X-Zyme General Information
Description
Developer and supplier of innovative enzymes and chiral products for the biocatalyst market. The company has developed a portfolio of enzyme libraries, chiral intermediates and single-enantiomer form of drugs, including chiral alcohols, diols and amins.
Contact Information
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Johnson Matthey Catalysis & Chiral Technologies
Primary Office
- Life Science Center
- Merowingerplatz 1A
- 40225 Dusseldorf
- Germany
X-Zyme Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
X-Zyme Patents
X-Zyme Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-10248277-A1 | Preparation of optically active 1-hydroxy-2-alkylaminoethane compounds, useful as bronchodilators for treating e.g. asthma, by reacting an amine with reactive 2-substituted ethanol, also new intermediates | Inactive | 16-Oct-2002 | 00000000 |
X-Zyme Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
